POST Online Media Lite Edition


Theravance appoints SVP, corporate partnerships, commercial

Staff writer |
San Francisco, Ca., USA - June 13, 2014, San Francisco, Ca., USA - Theravance, Inc., a royalty management company, announced the appointment of George B. Abercrombie, senior vice president, corporate partnerships, commercial.

With more than 30 years of experience as a business leader in the pharmaceutical industry, Mr. Abercrombie joins Theravance after serving as the President and Chief Executive Officer of Hoffmann-La Roche Inc. from 2001 to 2009 where he was responsible for the U.S. and Canada.

Prior to that, Mr. Abercrombie worked at Glaxo and its successor companies from 1993 to 2001, including as Senior Vice President of Commercial Operations for Glaxo Wellcome, Inc. with full P&L responsibility for all Marketing, Sales, Managed Care, State Government Affairs, eCommerce, Disease Management, Business Planning and Development, and Phase 3b/4 Clinical Studies over the period 1997 to 2001.

Mr. Abercrombie was most recently elected as Chairman of the Board of BioCryst Pharmaceuticals, Inc., and also serves as a Board member of numerous other healthcare-related organizations, including Project Hope and the North Carolina GlaxoSmithKline Foundation.


What to read next

Corcept Therapeutics appoints Renee Gala to board
Eric D'Esparbes joins Theravance as SVP, CFO
OncoMed appoints Rick Winningham to board of directors